drugset / Trial / NCT00039299

Biological Therapy in Treating Patients With Prostate Cancer

NCT00039299 ↗

Treatment

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop tumor cells from growing. Treating a person's T cells in the laboratory and then reinfusing them may cause a stronger immune response and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of T-cell therapy in treating patients who have prostate cancer that has not responded to hormone therapy.

Timeline

Start
2002-03
Primary completion
—
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Xcellerate Cell therapy — Other

Indications